Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Organic & Biomolecular Chemistry
|
July 12, 2018
Asymmetric organocatalytic synthesis of chiral 3,3-disubstituted oxindoles via a 1,6-conjugate addition reaction
Abdul Rahman, Qiaoxia Zhou, Xufeng Lin
International Journal of Legal Medicine
|
February 1, 2021
Association between monoamine oxidase A promoter polymorphism and the risk of sudden infant death syndrome: a meta-analysis
Qiaoxia Zhou, Daoyin Gong, Yu Zhang, et al.
The Journal of Organic Chemistry
|
August 29, 2018
Rhodium-Catalyzed Asymmetric Addition of Organoboronic Acids to Aldimines Using Chiral Spiro Monophosphite-Olefin Ligands: Method Development and Mechanistic Studies
Huanyu Shan, Qiaoxia Zhou, Jinglu Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 28, 2024
Bridging Smart Nanosystems with Clinically Relevant Models and Advanced Imaging for Precision Drug Delivery
Qiaoxia Zhou, Qiongliang Liu, Yan Wang, et al.
International Journal of Clinical and Experimental Medicine
|
November 10, 2015
Association of glutathione S-transferase T1, M1 and P1 polymorphisms in the breast cancer risk: a meta-analysis in Asian population
Jianqiu Tang, Qiaoxia Zhou, Fen Zhao, et al.
Scientific Reports
|
July 9, 2021
Screening of the HBx transactivation domain interacting proteins and the function of interactor Pin1 in HBV replication
Qiaoxia Zhou, Libo Yan, Baofu Xu, et al.
Clinical and Experimental Medicine
|
January 17, 2026
NF1/2 mutations predict favorable benefit from immune checkpoint inhibitor-based therapies over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma
Yi Sun, Qiang Cheng, Qiaoxia Zhou, et al.
Frontiers in Oncology
|
May 23, 2022
Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer
Zhiyu Wang, Zhuoqi Zhang, Ke Zhang, et al.
Iscience
|
January 5, 2024
Notch activation defines immune-suppressive subsets of ccRCCs with unfavorable benefits from immunotherapy over VEGFR/mTOR inhibitors
Sujun Han, Yu Xu, Dong Chen, et al.
Science China. Life Sciences
|
September 14, 2024
Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials
Jinliang Wang, Wenyong Zhou, Yu Xu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Organic & Biomolecular Chemistry
|
July 12, 2018
Asymmetric organocatalytic synthesis of chiral 3,3-disubstituted oxindoles via a 1,6-conjugate addition reaction
Abdul Rahman, Qiaoxia Zhou, Xufeng Lin
International Journal of Legal Medicine
|
February 1, 2021
Association between monoamine oxidase A promoter polymorphism and the risk of sudden infant death syndrome: a meta-analysis
Qiaoxia Zhou, Daoyin Gong, Yu Zhang, et al.
The Journal of Organic Chemistry
|
August 29, 2018
Rhodium-Catalyzed Asymmetric Addition of Organoboronic Acids to Aldimines Using Chiral Spiro Monophosphite-Olefin Ligands: Method Development and Mechanistic Studies
Huanyu Shan, Qiaoxia Zhou, Jinglu Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 28, 2024
Bridging Smart Nanosystems with Clinically Relevant Models and Advanced Imaging for Precision Drug Delivery
Qiaoxia Zhou, Qiongliang Liu, Yan Wang, et al.
International Journal of Clinical and Experimental Medicine
|
November 10, 2015
Association of glutathione S-transferase T1, M1 and P1 polymorphisms in the breast cancer risk: a meta-analysis in Asian population
Jianqiu Tang, Qiaoxia Zhou, Fen Zhao, et al.
Scientific Reports
|
July 9, 2021
Screening of the HBx transactivation domain interacting proteins and the function of interactor Pin1 in HBV replication
Qiaoxia Zhou, Libo Yan, Baofu Xu, et al.
Clinical and Experimental Medicine
|
January 17, 2026
NF1/2 mutations predict favorable benefit from immune checkpoint inhibitor-based therapies over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma
Yi Sun, Qiang Cheng, Qiaoxia Zhou, et al.
Frontiers in Oncology
|
May 23, 2022
Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer
Zhiyu Wang, Zhuoqi Zhang, Ke Zhang, et al.
Iscience
|
January 5, 2024
Notch activation defines immune-suppressive subsets of ccRCCs with unfavorable benefits from immunotherapy over VEGFR/mTOR inhibitors
Sujun Han, Yu Xu, Dong Chen, et al.
Science China. Life Sciences
|
September 14, 2024
Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials
Jinliang Wang, Wenyong Zhou, Yu Xu, et al.
Page
of 3